C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function.

Area of Science:

• Immunology
• Cell Biology

Background:

• C-reactive protein (CRP) is a key inflammation marker.
• Its precise role in modulating immune cell function remains incompletely understood.

Purpose of the Study:

• To investigate the impact of CRP on dendritic cell (DC) differentiation, activation, and function.
• To elucidate the underlying mechanisms of CRP's immunomodulatory effects.

Main Methods:

• Monocytes were isolated from peripheral blood mononuclear cells (PBMC) and differentiated into DCs in vitro.
• CRP's effects on DC surface marker expression (e.g., DC-SIGN, CD40, CD86, CD205, CD206, CD83) were assessed.
• Antigen uptake, T cell proliferation (mixed leukocyte reaction), and cytokine production were measured in CRP-treated DCs.

Main Results:

• CRP significantly down-regulated DC differentiation markers (DC-SIGN, CD40, CD86), particularly when added early.
• CRP reduced antigen uptake and inhibited DC maturation markers (CD40, CD80, CD86, CD83).
• CRP-treated DCs suppressed allogeneic T cell proliferation and decreased pro-inflammatory cytokine production (IL-6, IL-8, IL-12, TNF-alpha).

Conclusions:

• CRP inhibits dendritic cell differentiation, maturation, and function.
• These effects are primarily mediated through FcgammaRIIa/CD32.
• CRP plays a novel role in modulating the immune response by suppressing DC-mediated immune activation.